Back to results

Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

Primary Purpose

Cocaine-Related Disorders

Status

Terminated

Phase

Phase 1

Locations

United States

Study Type

Interventional

Intervention

Bupropion

About this trial

This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring Cocaine-Related Disorders

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: - Exclusion Criteria: -

Sites / Locations

VA Connecticut Healthcare System

Outcomes

Primary Outcome Measures

Side effects

Cocaine effects

Secondary Outcome Measures

Full Information

NCT ID

NCT00000276

First Posted

September 20, 1999

Last Updated

June 17, 2020

Sponsor

Yale University

Collaborators

National Institute on Drug Abuse (NIDA), VA Connecticut Healthcare System

1. Study Identification

Unique Protocol Identification Number

NCT00000276

Brief Title

Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

Official Title

Dopamine Reuptake Inhibitors of Cocaine Abuse

Study Type

Interventional

2. Study Status

Record Verification Date

June 2020

Overall Recruitment Status

Terminated

Study Start Date

September 1994 (undefined)

Primary Completion Date

August 1999 (Actual)

Study Completion Date

August 1999 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

Yale University

Collaborators

National Institute on Drug Abuse (NIDA), VA Connecticut Healthcare System

4. Oversight

5. Study Description

Brief Summary

The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Cocaine-Related Disorders

Keywords

Cocaine-Related Disorders

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 1

Enrollment

0 (false)

8. Arms, Groups, and Interventions

Intervention Type

Drug

Intervention Name(s)

Bupropion

Primary Outcome Measure Information:

Title

Side effects

Title

Cocaine effects

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Maximum Age & Unit of Time

45 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: - Exclusion Criteria: -

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Thomas R Kosten, M.D.

Organizational Affiliation

VA Connecticut Healthcare System

Official's Role

Principal Investigator

Facility Information:

Facility Name

VA Connecticut Healthcare System

City

New Haven

State/Province

Connecticut

ZIP/Postal Code

06519

Country

United States

12. IPD Sharing Statement

Learn more about this trial

Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

We'll reach out to this number within 24 hrs